{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T22:23:45Z","timestamp":1773008625740,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007560","name":"Chiesi Farmaceutici","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007560","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.ejphar.2019.172777","type":"journal-article","created":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T11:21:14Z","timestamp":1572866474000},"page":"172777","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Monocrotaline-induced pulmonary arterial hypertension: Time-course of injury and comparative evaluation of macitentan and Y-27632, a Rho kinase inhibitor"],"prefix":"10.1016","volume":"865","author":[{"given":"Deborah","family":"Novelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Fumagalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidia","family":"Staszewsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Ristagno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Olivari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serge","family":"Masson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daria","family":"De Giorgio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabina","family":"Ceriani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Affatato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"De Logu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romina","family":"Nassini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Milioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"Facchinetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Cantoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello","family":"Trevisani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Letizia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Salio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Latini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2019.172777_bib1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1161\/01.RES.0000111804.34509.94","article-title":"Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats","volume":"94","author":"Abe","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2019.172777_bib2","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1378\/chest.11-1460","article-title":"An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry","volume":"142","author":"Benza","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.ejphar.2019.172777_bib3","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejphar.2019.02.009","article-title":"Pharmacological characterization of a highly selective Rho kinase (ROCK) inhibitor and its therapeutic effects in experimental pulmonary hypertension","volume":"850","author":"Cantoni","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172777_bib4","doi-asserted-by":"crossref","first-page":"H184","DOI":"10.1152\/ajpheart.00181.2009","article-title":"Analysis of responses to the Rho-kinase inhibitor Y-27632 in the pulmonary and systemic vascular bed of the rat","volume":"299","author":"Casey","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2019.172777_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchf.2014.07.013","article-title":"Effect of macitentan on hospitalizations: results from the SERAPHIN trial","volume":"3","author":"Channick","year":"2015","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.ejphar.2019.172777_bib6","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1378\/chest.14-1004","article-title":"Hospitalization and survival in patients using epoprostenol for injection in the PROSPECT observational study","volume":"147","author":"Frantz","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.ejphar.2019.172777_bib7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0014-5793(98)01455-0","article-title":"The effects of the Rho-kinase inhibitor Y-27632 on arachidonic acid-, GTP gammaS-, and phorbol ester-induced Ca2+-sensitization of smooth muscle","volume":"440","author":"Fu","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejphar.2019.172777_bib8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"Gali\u00e8","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejphar.2019.172777_bib9","doi-asserted-by":"crossref","first-page":"L363","DOI":"10.1152\/ajplung.00212.2011","article-title":"The monocrotaline model of pulmonary hypertension in perspective","volume":"302","author":"Gomez-Arroyo","year":"2012","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.ejphar.2019.172777_bib10","article-title":"Primary pulmonary hypertension","volume":"352","author":"Gaine","year":"1998","journal-title":"Lancet 29"},{"key":"10.1016\/j.ejphar.2019.172777_bib11","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1378\/chest.14-0862","article-title":"New molecular targets of pulmonary vascular remodeling in pulmonary arterial hypertension: importance of endothelial communication","volume":"147","author":"Guignabert","year":"2015","journal-title":"Chest"},{"issue":"25 Suppl","key":"10.1016\/j.ejphar.2019.172777_bib12","doi-asserted-by":"crossref","first-page":"D42","DOI":"10.1016\/j.jacc.2013.10.032","article-title":"Definitions and diagnosis of pulmonary hypertension.","volume":"62","author":"Hoeper","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2019.172777_bib13","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1161\/CIRCRESAHA.116.305720","article-title":"Between Rho (k) and a hard place: the relation between vessel wall stiffness, endothelial contractility, and cardiovascular disease","volume":"116","author":"Huveneers","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2019.172777_bib14","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1124\/jpet.108.142976","article-title":"Pharmacology of macitentan, an orally active tissue-targeting dual endothelin receptor antagonist","volume":"327","author":"Iglarz","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2019.172777_bib15","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0026-895X(24)26508-1","article-title":"Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases","volume":"57","author":"Ishizaki","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172777_bib16","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/FJC.0b013e31802df112","article-title":"Acute vasodilator effect of fasudil, a Rho-kinase inhibitor, in monocrotaline-induced pulmonary hypertension in rats","volume":"49","author":"Jiang","year":"2007","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172777_bib17","doi-asserted-by":"crossref","first-page":"H364","DOI":"10.1152\/ajpheart.00979.2001","article-title":"Serial non invasive assessment of progressive pulmonary hypertension in a rat model","volume":"283","author":"Jones","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"8","key":"10.1016\/j.ejphar.2019.172777_bib18","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"29","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ejphar.2019.172777_bib19","doi-asserted-by":"crossref","first-page":"H1546","DOI":"10.1152\/ajpheart.00944.2011","article-title":"New mechanisms of pulmonary arterial hypertension: role of Ca2\u207asignaling","volume":"302","author":"Kuhr","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2019.172777_bib20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1161\/CIRCRESAHA.115.301146","article-title":"Pulmonary arterial hypertension: the clinical syndrome","volume":"115","author":"Lai","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2019.172777_bib21","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cardfail.2004.02.010","article-title":"Eplerenone, a selective aldosterone blocker, improves diastolic function in aged rats with small-to-moderate myocardial infarction","volume":"10","author":"Masson","year":"2004","journal-title":"J. Card. Fail."},{"issue":"25 Suppl. l","key":"10.1016\/j.ejphar.2019.172777_bib22","doi-asserted-by":"crossref","first-page":"D51","DOI":"10.1016\/j.jacc.2013.10.023","article-title":"Pulmonary arterial hypertension: epidemiology and registries","volume":"62","author":"McGoon","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2019.172777_bib23","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1161\/01.RES.73.5.887","article-title":"Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension","volume":"73","author":"Miyauchi","year":"1993","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2019.172777_bib24","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1183\/09031936.00130209","article-title":"Fasudil reduce monocrotaline-induced pulmonary arterial hypertension: comparison with bosentan and sildenafil","volume":"36","author":"Mouchaers","year":"2010","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejphar.2019.172777_bib25","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1164\/rccm.200405-637OC","article-title":"Et al. Inhaled Rho kinase inhibitors are potent and selective vasodilators in rat pulmonary hypertension","volume":"171","author":"Nagaoka","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2019.172777_bib26","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of echocardiography and the European association of cardiovascular imaging","volume":"29","author":"Nagueh","year":"2016","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.ejphar.2019.172777_bib27","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1213917","article-title":"Macitentan and morbidity and mortality in pulmonary arterial hypertension","volume":"369","author":"Pulido","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2019.172777_bib28","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/cvr\/cvu188","article-title":"Ranolazione prevents INaL enhancement and blunts myocardial remodeling in a model of pulmonary hypertension","volume":"104","author":"Rocchetti","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2019.172777_bib29","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.echo.2010.05.010","volume":"23","author":"Rudski","year":"2010","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.ejphar.2019.172777_bib30","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nrcardio.2011.87","article-title":"Mechanisms of disease: pulmonary arterial hypertension","volume":"8","author":"Schermuly","year":"2011","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ejphar.2019.172777_bib31","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0008-6363(99)00144-3","article-title":"Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm","volume":"43","author":"Shimokawa","year":"1999","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2019.172777_bib32","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s40262-015-0255-5","article-title":"Clinical pharmacokinetics and pharmacodynamics of the endothelin receptor antagonist macitentan","volume":"54","author":"Sidharta","year":"2015","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejphar.2019.172777_bib33","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/40187","article-title":"Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension","volume":"389","author":"Uehata","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2019.172777_bib34","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.vascn.2015.10.002","article-title":"Cross-laboratory analytical validation of the cardiac biomarker NT-proANP in rat","volume":"77","author":"Vinken","year":"2016","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ejphar.2019.172777_bib35","doi-asserted-by":"crossref","first-page":"H1854","DOI":"10.1152\/ajpheart.00595.2010","article-title":"Rescue treatment with a Rho-kinase inhibitor normalizes right ventricular function and reverses remodeling in juvenile rats with chronic pulmonary hypertension","volume":"299","author":"Xu","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2019.172777_bib36","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ejphar.2011.05.060","article-title":"Efficacy of aminaftone in a rat model of monocrotaline-induced pulmonary hypertension","volume":"667","author":"Zambelli","year":"2011","journal-title":"Eur. J. Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919307290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919307290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:34:44Z","timestamp":1757975684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299919307290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":36,"alternative-id":["S0014299919307290"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.172777","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monocrotaline-induced pulmonary arterial hypertension: Time-course of injury and comparative evaluation of macitentan and Y-27632, a Rho kinase inhibitor","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.172777","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"172777"}}